PATENT CLAIM ANALYSIS

Application Number: 15758709
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["544", "171000"]

Abstract:
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.

Claim (Index 137):
A method of treating or preventing inflammation in an intestinal region of a subject, comprising:\n administering to a gastrointestinal tract of the subject a therapeutically effective amount of one or more of the compounds of any one of  claims 1 - 117 , or a pharmaceutically acceptable salt or solvate thereof, thereby activating FXR receptors in the intestines, and thereby treating or preventing inflammation in the intestinal region of the subject.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.54839
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15758712', '15695911', '15023465', '13388502', '13821190']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7600511104012634
- 35 USC 102 Novelty (BERT): 0.5606923371710718
- Combined Prediction Score: 0.7401152330782442
- Mean Citation Score: 361.407644
- Max Citation Score: 488.3862
- Similarity Product: 303.26768206154105

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test